A management strategy that controls lower airway eosinophilic inflammation and symptoms reduced exacerbations in asthma

Adelsberg, Bernard
July 2003
ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p13
Academic Journal
Focuses on a management strategy that controls lower airway eosinophilic inflammation and symptoms reduced exacerbations in asthma. Main outcome measures; Results; Role of inflammation in the pathophysiology of asthma.


Related Articles

  • MTM essentials for asthma management: Part 1. Linder, Kristin E.; Sobieraj, Diana M. // Drug Topics;Apr2015, Vol. 159 Issue 4, p40 

    Inflammation is central in the pathophysiology of asthma and is a multicellular process. Bronchoconstriction is the dominant physiological event leading to the clinical symptoms of asthma, which most commonly include wheezing, cough, and dyspnea. As asthma progresses over time, the disease...

  • Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK). Heaney, Liam G.; Djukanovic, Ratko; Woodcock, Ashley; Walker, Samantha; Matthews, John G.; Pavord, Ian D.; Bradding, Peter; Niven, Robert; Brightling, Chris E.; Chaudhuri, Rekha; Arron, Joseph R.; Choy, David F.; Cowan, Douglas; Mansur, Adel; Menzies-Gow, Andrew; Adcock, Ian; Chung, Kian F.; Corrigan, Chris; Coyle, Peter; Harrison, Timothy // Thorax;Feb2016, Vol. 71 Issue 2, p187 

    The UK Refractory Asthma Stratification Programme (RASP-UK) will explore novel biomarker stratification strategies in severe asthma to improve clinical management and accelerate development of new therapies. Prior asthma mechanistic studies have not stratified on inflammatory phenotype and the...

  • Neue Erkenntnisse zur Pathophysiologie und Therapie der Gicht. A. So // Zeitschrift für Rheumatologie;Nov2007, Vol. 66 Issue 7, p562 

    Zusammenfassung  Gicht wird durch die Ablagerung von Mononatriumurat- (MNU-)Kristallen im Gewebe verursacht, durch die eine lokale Entz�ndungsreaktion ausgel�st wird. Bei �lteren Menschen ist sie die h�ufigste entz�ndliche...

  • Airway Smooth Muscle as a Target in Asthma and the Beneficial Effects of Bronchial Thermoplasty. Janssen, Luke J. // Journal of Allergy;2012, p1 

    Airflow within the airways is determined directly by the lumenal area of that airway. In this paper, we consider several factors which can reduce airway lumenal area, including thickening and/or active constriction of the airway smooth muscle (ASM). The latter cell type can also contribute in...

  • The anti-inflammatory effects of 1,1 dimethyl-4-phenylpiperazinium (DMPP) compared to dexamethasone in a guinea pig model of ovalbumin induced asthma. MURAD, H. A.; HASANIN, A. H. // European Review for Medical & Pharmacological Sciences;Aug2014, Vol. 18 Issue 15, p2228 

    BACKGROUD AND AIM: Inflammatory cells involved in the pathophysiology of asthma express nicotinic receptor. Therefore 1,1 dimethyl(-4-)phenylpiperazinium (DMPP) in two doses were compared to dexamethasone in asthmatic guinea pigs. MATERIALS AND METHODS: Six groups were included; Normal control...

  • Combination Therapeutic Approach for Asthma and Allergic Rhinitis. Chauhan, Bhupendrasinh; Patel, Madhabhai; Padh, Harish; Nivsarkar, Manish // Current Clinical Pharmacology;Sep2008, Vol. 3 Issue 3, p185 

    Background: Asthma and allergic rhinitis are symptomatically as well as pathophysiologically overlapping conditions and their prevalence is increasing at an alarming rate. Despite significant progress in pathophysiology of asthma and allergic rhinitis and availability of several therapies in...

  • Statins in Asthma: Potential Beneficial Effects and Limitations. Bhattacharjee, Dipanjan; Chogtu, Bharti; Magazine, Rahul // Pulmonary Medicine;11/5/2015, p1 

    Asthma’s sustenance as a global pandemic, across centuries, can be attributed to the lack of an understanding of its workings and the inability of the existing treatment modalities to provide a long lasting cure without major adverse effects. The discovery of statins boosted by a better...

  • Omalizumab Therapy for Patients With Severe Asthma.  // Annals of Internal Medicine;5/3/2011, Vol. 154 Issue 9, pI-28 

    The article offers information on the use of omalizumab in treating patients with severe asthma. Asthma is a common illness wherein inflammation and constriction of the airways cause symptoms including wheezing, coughing, and shortness of breath. Omalizumab is a medication which stops the...

  • Determining the role of allergy in sinonasal disease. Settipane, Russell A.; Borish, Larry; Peters, Anju T. // American Journal of Rhinology & Allergy;May/Jun2013 Supplement, pS56 

    The contributing role of specific IgE sensitization in the pathophysiology of sinonasal diseases including rhinitis, chronic rhinosinusitis (CRS), and nasal polyps is explored. Although it is estimated that sensitization to environmental allergens is present in 75% of patients with rhinitis, the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics